Loading…
Traded Jan 15, 2026 · Filed Jan 17, 2026
Ciena's SVP Global R&D sold $622K of Ciena shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$622,223
Shares × reported transaction price
35 days after results of Dec 11, 2025, 49 days before results of Mar 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $243.79 on Jan 15, 2026, 356% above its 52-week low and 6% below its high, after a 20% rise over the previous 30 trading days
52-week range $53.50 (Apr 4, 2025) to $259.27 (Jan 7, 2026), 92% of the way up, from 251 adjusted closes. 30 trading days earlier: $202.50 on Dec 2, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.6% | +2.6% | -0.0% |
| 30 days | +32.0% | +1.0% | +31.0% |
| 90 days | +108.6% | +4.6% | +104.0% |
| 180 days | +57.0% | +9.5% | +47.5% |
Past results only. Not a forecast.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
